OpenSAFELY
Reports

Vaccine Coverage

Description
Weekly* report on COVID-19 vaccination coverage in England, based on the population of 23.4m people registered with practices that use TPP SystmOne software. * please note, updates will occur most weeks but not all.
Contact
Get in touch and tell us how you use this report or new features you'd like to see: [email protected]
First published
22 Dec 2020
Last updated
30 Nov 2021
Links

OpenSAFELY COVID Vaccine coverage report

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

This is our regular weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of January 13th) in our preprint paper available here.

The full analytical methods behind the latest results in this report are available here.

Report last updated 30 Nov 2021

Vaccinations included up to 24 Nov 2021 inclusive

Contents:

Overview of Vaccination Figures to date

Group definitions

  • As of 29 Nov 2021, patient age is calculated at 31 Aug 2021 (previously 31 March 2021), in line with national reporting.
  • The care home group is defined based on patients (aged 65+) having one of these codes.
  • The shielding group is defined based on patients (aged 16-69) having one of these codes provided it was not superceded by one of these codes.
  • The LD (learning disability) group is defined based on patients (aged 16-64) having one of these codes and excludes people who are shielding.
  • Patients are counted in their highest risk category only; e.g. a 65-year-old who is shielding is only counted in the shielding group, not in the 65-69 group.
  • The housebound group is defined based on this codelist and excludes people who were later recorded as not housebound or in a care home. ####
first dose as at 24 Nov 2021 second dose as at 24 Nov 2021 third dose as at 24 Nov 2021
Group
Total vaccinated in TPP 16,458,435 15,451,905 5,582,304
80+ 96.8% (1,066,877 of 1,102,570) 95.8% (1,056,153 of 1,102,570) 81.5% (898,989 of 1,102,570)
70-79 96.2% (2,018,478 of 2,097,998) 95.3% (1,999,249 of 2,097,998) 80.1% (1,680,385 of 2,097,998)
care home 96.7% (106,323 of 109,900) 93.2% (102,431 of 109,900) 74.3% (81,620 of 109,900)
shielding (aged 16-69) 91.4% (755,314 of 826,777) 88.4% (730,863 of 826,777) 48.6% (401,569 of 826,777)
65-69 93.7% (1,018,934 of 1,087,107) 92.5% (1,005,179 of 1,087,107) 61.2% (665,700 of 1,087,107)
LD (aged 16-64) 87.4% (74,200 of 84,945) 82.5% (70,091 of 84,945) 23.2% (19,670 of 84,945)
60-64 91.9% (1,200,430 of 1,305,633) 90.4% (1,180,907 of 1,305,633) 37.9% (494,564 of 1,305,633)
55-59 90.0% (1,381,975 of 1,534,799) 88.2% (1,354,430 of 1,534,799) 26.3% (403,620 of 1,534,799)
50-54 87.7% (1,384,698 of 1,578,773) 85.5% (1,349,383 of 1,578,773) 21.2% (334,145 of 1,578,773)
40-49 80.2% (2,393,650 of 2,984,037) 76.7% (2,289,511 of 2,984,037) 10.0% (297,339 of 2,984,037)
30-39 70.4% (2,374,904 of 3,372,537) 64.8% (2,184,210 of 3,372,537) 5.6% (188,706 of 3,372,537)
18-29 67.7% (2,361,212 of 3,490,249) 58.9% (2,055,760 of 3,490,249) 3.3% (113,729 of 3,490,249)
16-17 60.3% (321,447 of 533,456) 13.8% (73,745 of 533,456) 0.4% (2,282 of 533,456)

NB Patient counts are rounded to nearest 7

Second doses are at least 19 days after the first; third doses at least 8 weeks after the second;

All second and third/booster doses given in these timescales are counted whether or not they were 'due' according to the relevant dosing schedule at the time.

Vaccine types

Note: numbers may not sum to 100% as it is not always possible to determine vaccine type given, and patients occasionally have more than one brand recorded on the same day.

Oxford-AZ vaccines (% of all first doses): 51.0% (8,399,279)

Pfizer vaccines (% of all first doses): 46.5% (7,649,677)

Moderna vaccines (% of all first doses): 2.5% (413,427)

Second doses and dose combinations

Note: second dose figures are raw proportions and do not take into account how many are due, which is likely to vary substantially by brand.
For more detailed analysis please refer to our second dose report

Second doses (% of all vaccinated): 93.9% (15,451,905)

Second doses (% of Ox-AZ first doses): 98.0% (8,231,545)

Second doses (% of Pfizer first doses): 89.7% (6,861,197)

Second doses (% of Moderna first doses): 88.2% (364,525)


Note: mixed doses counts patients with first and second doses at least 19 days apart, excluding patients with two different brands recorded on the same day or recorded on a date prior to when the given brand was available in the UK

Mixed doses Ox-AZ + Pfizer (% of fully vaccinated): 0.4% (57729)

Mixed doses Ox-AZ + Moderna (% of fully vaccinated): 0.0% (3668)

Mixed doses Moderna + Pfizer (% of fully vaccinated): 0.0% (5047)

Summary Charts

Note: 'Priority groups' only includes those identified as being in a priority group by our methodology. 'Others' includes everyone aged 18-49 except those who are shielding or have a learning disability.

Trends in vaccination rates of 80+ population according to demographic/clinical features, cumulatively by day.

*Latest overall cohort rate calculated as at latest date for vaccinations recorded across all TPP practices.

80+ population

COVID vaccinations among 80+ population

by Sex

COVID vaccinations among 80+ population

by Ethnicity (broad categories)

COVID vaccinations among 80+ population

by Index of Multiple Deprivation (quintiles)

COVID vaccinations among 80+ population

by BMI